Variable expressivity of BEST1-associated autosomal dominant vitreoretinochoroidopathy (ADVIRC) in a three-generation pedigree
Open Access
- 21 October 2021
- journal article
- research article
- Published by BMJ in BMJ Open Ophthalmology
- Vol. 6 (1), e000813
- https://doi.org/10.1136/bmjophth-2021-000813
Abstract
Objective Autosomal dominant vitreoretinochoroidopathy (ADVIRC) is associated with pathogenic variants in BEST1, which typically causes visual impairment in the late stage of disease. We present a pedigree with variable expressivity and the youngest case in the literature with visual impairment in early childhood. Methods and analysis This is a retrospective, observational, case series describing multigenerational members of one family affected with ADVIRC. Patients underwent examination, ultra-widefield fundus photography and angiography, optical coherence tomography, full-field electroretinography (ffERG) and full-field perimetry. Results Three affected members of the pedigree, one from each successive generation, were found to harbour a mutation, c.715G>A:p.Val239Met, in BEST1. The proband characterised in this report is, to our knowledge, the youngest documented case of ADVIRC in early childhood. Yet, this patient has the most severe retinal dysfunction compared with the father and paternal grandmother, whom exhibit classic characteristics of ADVIRC. Longitudinal data from the paternal grandmother showed that there was a rapid decline in ffERG responses (photopic decline worse than scotopic) from the fourth to fifth decade of life, which correlated with severe concentric constriction of visual fields. Conclusion This multigenerational case series provides new insights into the ADVIRC disease spectrum and rate of progression. While ADVIRC typically causes a slowly progressive disease, we show that variable phenotypic expressivity is possible among affected members of the same family with the same mutation in BEST1. Thus, ADVIRC must also be considered in the differential diagnosis of paediatric patients with severe retinal dystrophy in early childhood.Funding Information
- NIH NEI (R01EY018571, R01EY022356)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- NIH (K08EY026650)
- Foundation Fighting Blindness (CD-NMT-0714-0648)
This publication has 34 references indexed in Scilit:
- Calpain-5 Mutations Cause Autoimmune Uveitis, Retinal Neovascularization, and Photoreceptor DegenerationPLoS Genetics, 2012
- BEST1 expression in the retinal pigment epithelium is modulated by OTX family membersHuman Molecular Genetics, 2008
- Differential Macular and Peripheral Expression of Bestrophin in Human Eyes and Its Implication for Best DiseaseInvestigative Ophthalmology & Visual Science, 2007
- VMD2 Promoter Requires Two Proximal E-box Sites for Its Activity in Vivo and Is Regulated by the MITF-TFE FamilyOnline Journal of Public Health Informatics, 2007
- Central Cone Dysfunction in Autosomal Dominant Vitreoretino Choroidopathy (ADVIRC)American Journal of Ophthalmology, 2006
- Mutations ofVMD2Splicing Regulators Cause Nanophthalmos and Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC)Investigative Ophthalmology & Visual Science, 2004
- Analysis of the VMD2 Promoter and Implication of E-box Binding Factors in Its RegulationOnline Journal of Public Health Informatics, 2004
- Phenotype and genotype correlations in two best familiesOphthalmology, 2003
- Molecular evidence for non-penetrance in Best's disease.Journal of Medical Genetics, 1994
- Autosomal dominant vitreoretinochoroidopathy (ADVIRC).British Journal of Ophthalmology, 1984